Power Vision’s mission is to provide a family of fluid-based lens implants that meet the clinical and lifestyle needs caused by these conditions, and develop the most significant innovation in vision correction surgery since the introduction of the intraocular lens.
The Fluid Vision lens is an investigational device that is not available for sale and is available for use only by the investigators participating in the multi-center clinical study. is a private company focused on developing a novel accommodating intraocular lens, which, it believes, will be the first to restore True Accommodation™.
Intraocular lens technology has improved dramatically during the last twenty years.
The majority of implants used today are foldable acrylic one-piece IOLs, most of which have aspheric optics.
Multifocal IOLs: Most multifocal lenses are actually bifocal lenses.
However, there are now trifocal lenses that have the advantage of better intermediate vision.
Advances in astigmatism-correcting and presbyopia-correcting lenses now offer reduced dependence on glasses to a greater number of patients.
However, only a few of these designs are FDA approved.Marchini et al reported the mean anterior axial movement of 20 crystalens IOLs to be only 0.33 ± 0.25mm 2004;76-2482).Yet, despite a mean accommodative amplitude of 1.08 ± 0.54 D (range 0-2.25), 86% of patients in this study required no correction for near vision during routine daily activities.This article will explore the available accommodative technologies under these 3 headings including any limitations concerning lens excursion and accommodative amplitude and examine the potential impact of these IOLs on cataract and refractive surgeons and patients.The Morcher Bio Com Fold Type 43E, Human Optics 1 CU, Lenstec Tetra Flex, and eyeonics crystalens are examples of single-optic IOLs.The Morcher Bio Comfold 43E is a single-optic/ring haptic lens.